HairDx Analytical Validation Study
NCT04379583 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-07-21
Summary
The HairDx Test reports genetic variants associated with the development of FPHL.
Conditions
- Hair Loss
- Hair Loss/Baldness
- Female Pattern Baldness
- Androgenetic Alopecia
Interventions
- DEVICE
-
HairDx Sample Collection Kit
Saliva collection using FDA OTC cleared sample collection device
Sponsors & Collaborators
-
Applied Biology, Inc.
lead INDUSTRY
Principal Investigators
-
John McCoy, PhD · Applied Biology, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-15
- Primary Completion
- 2021-12-06
- Completion
- 2021-12-06
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
NCT03662854 ·Status: UNKNOWN ·Phase: PHASE1
-
ENERGI-F701 for Female Hair Loss Treatment
NCT03351322 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia
NCT05332366 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
NCT06854432 ·Status: TERMINATED ·Phase: NA
-
The Analysis of Hair Count in Healthy Taiwanese Persons by Trichoscope
NCT03937557 ·Status: WITHDRAWN ·Phase: NA
-
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT02206802 ·Status: COMPLETED
-
A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss
NCT01451099 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
NCT06515496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)
NCT01451112 ·Status: COMPLETED ·Phase: PHASE2
-
Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia
NCT01052870 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenomic Study of Androgenetic Alopecia
NCT01227031 ·Status: UNKNOWN
-
Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata
NCT06104839 ·Status: RECRUITING ·Phase: PHASE2
-
PAI-1 Expression in Non-scarring Hair Loss
NCT02548689 ·Status: TERMINATED
-
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
NCT07133308 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of VDPHL01 in Males With AGA
NCT06724614 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia
NCT07327359 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
NCT00177099 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata
NCT05556265 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Androgenetic Alopecia in Females, 9 Beam
NCT00981461 ·Status: COMPLETED ·Phase: NA
-
Hair Up Prospective Study
NCT03652701 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss
NCT01451021 ·Status: COMPLETED ·Phase: PHASE2
-
Low Level Light Device as a Primary Therapy for Androgenetic Alopecia
NCT04558242 ·Status: UNKNOWN ·Phase: NA
-
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
NCT03491267 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
NCT01451177 ·Status: COMPLETED ·Phase: PHASE2